Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125305181 | 12530518 | 1 | I | 20160628 | 20160706 | 20160706 | EXP | US-GLAXOSMITHKLINE-US2016GSK095674 | GLAXOSMITHKLINE | GAJUREL K, GOMEZ CA, DHAKAL H, MONTAYA JG. FAILURE OF PRIMARY ATOVAQUONE PROPHYLAXIS FOR PREVENTION OF TOXOPLASMOSIS IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS. TRANSPLANT INFECTIOUS DISEASE. 2016;18:446-452 | 46.00 | YR | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125305181 | 12530518 | 1 | PS | ATOVAQUONE. | ATOVAQUONE | 1 | 1500 MG, TID | 20259 | 1500 | MG | TID | ||||||||
| 125305181 | 12530518 | 2 | SS | GANCICLOVIR. | GANCICLOVIR | 1 | 0 | ||||||||||||
| 125305181 | 12530518 | 3 | C | FOSCARNET | FOSCARNET | 1 | 0 | ||||||||||||
| 125305181 | 12530518 | 4 | C | CIDOFOVIR. | CIDOFOVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125305181 | 12530518 | 1 | Antifungal prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125305181 | 12530518 | DE |
| 125305181 | 12530518 | HO |
| 125305181 | 12530518 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125305181 | 12530518 | Adenovirus infection | |
| 125305181 | 12530518 | Cognitive disorder | |
| 125305181 | 12530518 | Computerised tomogram thorax abnormal | |
| 125305181 | 12530518 | Condition aggravated | |
| 125305181 | 12530518 | Cytomegalovirus infection | |
| 125305181 | 12530518 | Death | |
| 125305181 | 12530518 | Deep vein thrombosis | |
| 125305181 | 12530518 | Drug resistance | |
| 125305181 | 12530518 | Generalised tonic-clonic seizure | |
| 125305181 | 12530518 | Hypoxia | |
| 125305181 | 12530518 | Infarction | |
| 125305181 | 12530518 | Pneumonitis | |
| 125305181 | 12530518 | Pyrexia | |
| 125305181 | 12530518 | Respiratory failure | |
| 125305181 | 12530518 | Somnolence | |
| 125305181 | 12530518 | Thrombocytopenia | |
| 125305181 | 12530518 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |